STOCK TITAN

Quaker Chemical Financials

KWR
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Quaker Chemical (KWR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 41 / 100
Financial Profile 41/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability
28

Quaker Chemical has an operating margin of 2.8%, meaning the company retains $3 of operating profit per $100 of revenue. This below-average margin results in a low score of 28/100, suggesting thin profitability after operating expenses. This is down from 10.6% the prior year.

Growth
38

Quaker Chemical's revenue grew a modest 2.7% year-over-year to $1.9B. This slow but positive growth earns a score of 38/100.

Leverage
90

Quaker Chemical carries a low D/E ratio of 0.61, meaning only $0.61 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 90/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
45

Quaker Chemical's current ratio of 2.42 indicates adequate short-term liquidity, earning a score of 45/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
36

Quaker Chemical has a free cash flow margin of 4.3%, earning a moderate score of 36/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
11

Quaker Chemical generates a -0.2% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 11/100. This is down from 8.6% the prior year.

Altman Z-Score Grey Zone
2.15

Quaker Chemical scores 2.15, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Piotroski F-Score Neutral
4/9

Quaker Chemical passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed
-54.84x

For every $1 of reported earnings, Quaker Chemical generates $-54.84 in operating cash flow ($136.5M OCF vs -$2.5M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk
1.2x

Quaker Chemical earns $1.2 in operating income for every $1 of interest expense ($53.0M vs $42.6M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.9B
YoY+2.7%
5Y CAGR+5.9%
10Y CAGR+9.9%

Quaker Chemical generated $1.9B in revenue in fiscal year 2025. This represents an increase of 2.7% from the prior year.

EBITDA
$118.8M
YoY-53.5%
5Y CAGR+0.3%
10Y CAGR+3.8%

Quaker Chemical's EBITDA was $118.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 53.5% from the prior year.

Net Income
-$2.5M
YoY-102.1%

Quaker Chemical reported -$2.5M in net income in fiscal year 2025. This represents a decrease of 102.1% from the prior year.

EPS (Diluted)
$-0.14
YoY-102.2%

Quaker Chemical earned $-0.14 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 102.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$80.6M
YoY-50.5%
5Y CAGR-12.9%
10Y CAGR+2.6%

Quaker Chemical generated $80.6M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 50.5% from the prior year.

Cash & Debt
$179.8M
YoY-4.8%
5Y CAGR-0.2%
10Y CAGR+8.3%

Quaker Chemical held $179.8M in cash against $834.9M in long-term debt as of fiscal year 2025.

Dividends Per Share
$1.99
YoY+5.9%
5Y CAGR+5.0%
10Y CAGR+4.7%

Quaker Chemical paid $1.99 per share in dividends in fiscal year 2025. This represents an increase of 5.9% from the prior year.

Shares Outstanding
17M
YoY-1.9%
5Y CAGR-0.6%
10Y CAGR+2.8%

Quaker Chemical had 17M shares outstanding in fiscal year 2025. This represents a decrease of 1.9% from the prior year.

Margins & Returns

Gross Margin
36.0%
YoY-1.3pp
5Y CAGR-0.3pp
10Y CAGR-1.7pp

Quaker Chemical's gross margin was 36.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.3 percentage points from the prior year.

Operating Margin
2.8%
YoY-7.8pp
5Y CAGR-1.4pp
10Y CAGR-7.3pp

Quaker Chemical's operating margin was 2.8% in fiscal year 2025, reflecting core business profitability. This is down 7.8 percentage points from the prior year.

Net Margin
-0.1%
YoY-6.5pp
5Y CAGR-2.9pp
10Y CAGR-7.1pp

Quaker Chemical's net profit margin was -0.1% in fiscal year 2025, showing the share of revenue converted to profit. This is down 6.5 percentage points from the prior year.

Return on Equity
-0.2%
YoY-8.8pp
5Y CAGR-3.2pp
10Y CAGR-13.9pp

Quaker Chemical's ROE was -0.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 8.8 percentage points from the prior year.

Capital Allocation

R&D Spending
$60.7M
YoY+5.9%
5Y CAGR+8.7%
10Y CAGR+10.6%

Quaker Chemical invested $60.7M in research and development in fiscal year 2025. This represents an increase of 5.9% from the prior year.

Share Buybacks
$41.5M
YoY-15.7%
10Y CAGR+19.0%

Quaker Chemical spent $41.5M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 15.7% from the prior year.

Capital Expenditures
$55.9M
YoY+33.6%
5Y CAGR+25.6%
10Y CAGR+17.6%

Quaker Chemical invested $55.9M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 33.6% from the prior year.

KWR Income Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Revenue $468.5M-5.1% $493.8M+2.2% $483.4M+9.1% $442.9M-0.3% $444.1M-3.9% $462.3M-0.3% $463.6M-1.3% $469.8M
Cost of Revenue $303.0M-3.2% $313.0M+0.4% $311.7M+10.7% $281.7M-2.2% $287.9M-0.6% $289.7M+0.7% $287.8M-0.1% $288.2M
Gross Profit $165.5M-8.5% $180.9M+5.3% $171.7M+6.5% $161.3M+3.2% $156.2M-9.5% $172.5M-1.8% $175.7M-3.2% $181.6M
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $130.3M+3.0% $126.5M-0.1% $126.6M+6.3% $119.0M-5.1% $125.4M+6.1% $118.2M+1.1% $116.9M-5.8% $124.2M
Operating Income $31.2M-33.0% $46.6M+188.8% -$52.5M-290.1% $27.6M-4.8% $29.0M-43.9% $51.7M-11.5% $58.4M+5.3% $55.5M
Interest Expense $10.4M-1.5% $10.6M-14.8% $12.4M+35.2% $9.2M-4.6% $9.6M-10.6% $10.8M-6.6% $11.5M+2.2% $11.3M
Income Tax $2.3M-74.9% $9.3M+69.3% $5.5M-27.4% $7.5M-14.8% $8.8M-27.3% $12.2M-22.9% $15.8M+26.1% $12.5M
Net Income $20.7M-32.1% $30.5M+145.8% -$66.6M-615.2% $12.9M-8.9% $14.2M-56.1% $32.3M-7.3% $34.9M-1.0% $35.2M
EPS (Diluted) N/A $1.75+146.3% $-3.78-617.8% $0.73 N/A $1.81-6.7% $1.94-0.5% $1.95

KWR Balance Sheet

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Total Assets $2.8B-0.7% $2.8B-1.1% $2.8B+6.9% $2.7B+2.1% $2.6B-4.6% $2.7B+2.4% $2.7B-1.6% $2.7B
Current Assets $921.2M-2.6% $946.0M-2.9% $974.1M+6.8% $912.4M+4.1% $876.4M-6.9% $941.9M+2.5% $919.1M-1.5% $933.0M
Cash & Equivalents $179.8M+4.5% $172.0M-14.8% $201.9M+8.4% $186.2M-1.4% $188.9M-10.9% $212.1M+12.5% $188.6M-3.7% $195.8M
Inventory $265.8M N/A N/A N/A $227.5M N/A N/A N/A
Accounts Receivable $417.2M-4.4% $436.2M-0.3% $437.4M+4.5% $418.7M+4.6% $400.1M-5.3% $422.7M-0.3% $423.9M-3.7% $440.0M
Goodwill $501.7M0.0% $501.8M-0.1% $502.4M-4.2% $524.7M+1.1% $518.9M-2.6% $532.5M+2.9% $517.6M-1.0% $522.6M
Total Liabilities $1.4B-2.0% $1.4B-3.6% $1.5B+17.6% $1.3B+1.7% $1.3B-2.6% $1.3B+1.0% $1.3B-3.5% $1.3B
Current Liabilities $380.2M-0.8% $383.4M+0.9% $380.1M+1.9% $372.8M-1.8% $379.8M+2.3% $371.3M+6.1% $350.1M0.0% $350.2M
Long-Term Debt $834.9M-0.4% $838.5M-6.6% $898.0M+28.5% $698.8M+4.4% $669.6M-4.4% $700.6M-0.4% $703.7M-5.0% $740.4M
Total Equity $1.4B+0.7% $1.4B+1.6% $1.3B-3.1% $1.4B+2.4% $1.4B-6.4% $1.4B+3.6% $1.4B+0.3% $1.4B
Retained Earnings $596.6M+2.0% $584.7M+3.8% $563.1M-11.8% $638.1M+0.7% $633.7M+0.9% $628.1M+3.9% $604.4M+4.6% $577.7M

KWR Cash Flow Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Operating Cash Flow $46.5M-9.4% $51.4M+23.6% $41.6M+1463.0% -$3.0M-104.8% $63.1M-7.2% $68.0M+46.8% $46.3M+70.0% $27.2M
Capital Expenditures $22.2M+66.6% $13.3M+67.6% $8.0M-35.4% $12.3M-45.1% $22.5M+173.4% $8.2M+23.2% $6.7M+49.4% $4.5M
Free Cash Flow $24.3M-36.1% $38.0M+13.2% $33.6M+318.6% -$15.4M-137.9% $40.6M-32.1% $59.8M+50.8% $39.6M+74.1% $22.8M
Investing Cash Flow -$21.1M-71.6% -$12.3M+92.6% -$167.3M-1147.5% -$13.4M+34.8% -$20.6M+9.0% -$22.6M-476.4% -$3.9M+86.6% -$29.3M
Financing Cash Flow -$17.4M+74.5% -$68.3M-150.0% $136.6M+1146.8% $11.0M+119.7% -$55.7M-100.9% -$27.7M+39.6% -$45.9M-798.8% $6.6M
Dividends Paid $8.8M+4.4% $8.4M-1.6% $8.6M0.0% $8.6M-0.9% $8.6M+6.1% $8.2M-0.4% $8.2M0.0% $8.2M
Share Buybacks $5.0M+32.1% $3.8M N/A N/A $26.3M+73.9% $15.1M N/A N/A

KWR Financial Ratios

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Gross Margin 35.3%-1.3pp 36.6%+1.1pp 35.5%-0.9pp 36.4%+1.2pp 35.2%-2.2pp 37.3%-0.6pp 37.9%-0.7pp 38.6%
Operating Margin 6.7%-2.8pp 9.4%+20.3pp -10.9%-17.1pp 6.2%-0.3pp 6.5%-4.7pp 11.2%-1.4pp 12.6%+0.8pp 11.8%
Net Margin 4.4%-1.7pp 6.2%+19.9pp -13.8%-16.7pp 2.9%-0.3pp 3.2%-3.8pp 7.0%-0.5pp 7.5%+0.0pp 7.5%
Return on Equity 1.5%-0.7pp 2.2%+7.2pp -5.0%-5.9pp 0.9%-0.1pp 1.1%-1.2pp 2.2%-0.3pp 2.5%-0.0pp 2.5%
Return on Assets 0.7%-0.3pp 1.1%+3.4pp -2.3%-2.8pp 0.5%-0.1pp 0.5%-0.6pp 1.2%-0.1pp 1.3%+0.0pp 1.3%
Current Ratio 2.42-0.0 2.47-0.1 2.56+0.1 2.45+0.1 2.31-0.2 2.54-0.1 2.63-0.0 2.66
Debt-to-Equity 0.610.0 0.61-0.1 0.67+0.2 0.500.0 0.490.0 0.48-0.0 0.50-0.0 0.53
FCF Margin 5.2%-2.5pp 7.7%+0.7pp 7.0%+10.4pp -3.5%-12.6pp 9.1%-3.8pp 12.9%+4.4pp 8.6%+3.7pp 4.9%

Similar Companies

Frequently Asked Questions

Quaker Chemical (KWR) reported $1.9B in total revenue for fiscal year 2025. This represents a 2.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Quaker Chemical (KWR) revenue grew by 2.7% year-over-year, from $1.8B to $1.9B in fiscal year 2025.

No, Quaker Chemical (KWR) reported a net income of -$2.5M in fiscal year 2025, with a net profit margin of -0.1%.

Quaker Chemical (KWR) reported diluted earnings per share of $-0.14 for fiscal year 2025. This represents a -102.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Quaker Chemical (KWR) had EBITDA of $118.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Quaker Chemical (KWR) had $179.8M in cash and equivalents against $834.9M in long-term debt.

Quaker Chemical (KWR) had a gross margin of 36.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Quaker Chemical (KWR) had an operating margin of 2.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Quaker Chemical (KWR) had a net profit margin of -0.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Quaker Chemical (KWR) paid $1.99 per share in dividends during fiscal year 2025.

Quaker Chemical (KWR) has a return on equity of -0.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Quaker Chemical (KWR) generated $80.6M in free cash flow during fiscal year 2025. This represents a -50.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Quaker Chemical (KWR) generated $136.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Quaker Chemical (KWR) had $2.8B in total assets as of fiscal year 2025, including both current and long-term assets.

Quaker Chemical (KWR) invested $55.9M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Quaker Chemical (KWR) invested $60.7M in research and development during fiscal year 2025.

Yes, Quaker Chemical (KWR) spent $41.5M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Quaker Chemical (KWR) had 17M shares outstanding as of fiscal year 2025.

Quaker Chemical (KWR) had a current ratio of 2.42 as of fiscal year 2025, which is generally considered healthy.

Quaker Chemical (KWR) had a debt-to-equity ratio of 0.61 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Quaker Chemical (KWR) had a return on assets of -0.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Quaker Chemical (KWR) has an Altman Z-Score of 2.15, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Quaker Chemical (KWR) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Quaker Chemical (KWR) has an earnings quality ratio of -54.84x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Quaker Chemical (KWR) has an interest coverage ratio of 1.2x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Quaker Chemical (KWR) scores 41 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top